GenMont Biotech Incorporation announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 118.393 million compared to TWD 110.301 million a year ago. Operating income was TWD 43.364 million compared to TWD 41.751 million a year ago. Net income was TWD 36.193 million compared to TWD 22.986 million a year ago. Basic earnings per share from continuing operations was TWD 0.41 compared to TWD 0.45 a year ago. Basic earnings per share was TWD 0.41 compared to TWD 0.26 a year ago. For the nine months, sales was TWD 311.921 million compared to TWD 307.661 million a year ago. Operating income was TWD 93.763 million compared to TWD 102.432 million a year ago. Net income was TWD 133.320 million compared to TWD 61.596 million a year ago. Basic earnings per share from continuing operations was TWD 0.83 compared to TWD 1.37 a year ago. Basic earnings per share was TWD 1.5 compared to TWD 0.69 a year ago. Diluted earnings per share was TWD 1.49 compared to TWD 0.69 a year ago.